Mood and physiological effects of subcutaneous nicotine in smokers and never-smokers

被引:65
作者
Foulds, J [1 ]
Stapleton, JA [1 ]
Bell, N [1 ]
Swettenham, J [1 ]
Jarvis, MJ [1 ]
Russell, MAH [1 ]
机构
[1] INST PSYCHIAT, HLTH BEHAV UNIT, LONDON SE5 8AF, ENGLAND
基金
英国医学研究理事会;
关键词
nicotine; smokers; non-smokers; mood; subjective effects; heart-rate; tolerance;
D O I
10.1016/S0376-8716(96)01327-0
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
This study compared the effect of subcutaneous nicotine injections (2 x 0.3 mg and 2 x 0.6 mg) with saline on subjective and physiological measures in 18 never-smokers and 18 smokers (24-h nicotine deprived), under conditions of rest and cognitive testing. Prior to the injections the mood of the smokers bad deteriorated to a level significantly below that of the never-smokers as a result of tobacco withdrawal. Cognitive tests caused reductions in calmness and increased alertness but there was no evidence of nicotine improving mood in either group under either condition. The 0.6 mg dose worsened mood in never-smokers and caused unpleasant symptoms (e.g. dizziness and arm pain) in both groups. Compared with smokers, never-smokers experienced stronger symptoms of nicotine toxicity and a greater reduction in alertness in response to the 0.6 mg dose, suggesting chronic tolerance to some nicotine effects in smokers. Nicotine produced similar increases in heart rate and decreases in finger pulse volume in both groups. Our results imply that if nicotine has a mood enhancing effect it occurs only after tolerance has been acquired to its primary adverse effects, and that its ability to reverse the mood deterioration caused by tobacco withdrawal is susceptible to situational factors such as our experimental conditions. (C) 1997 Elseveier Science Ireland Ltd.
引用
收藏
页码:105 / 115
页数:11
相关论文
共 39 条
[1]  
[Anonymous], 1988, HLTH CONS SMOK NIC A
[2]   BIPHASIC DOSE-RELATED RESPONSES OF THE CNV (CONTINGENT NEGATIVE-VARIATION) TO IV NICOTINE IN MAN [J].
ASHTON, H ;
MARSH, VR ;
MILLMAN, JE ;
RAWLINS, MD ;
TELFORD, R ;
THOMPSON, JW .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 10 (06) :579-589
[3]  
BENOWITZ NL, 1988, NEW ENGL J MED, V319, P1318
[4]   CIRCADIAN BLOOD NICOTINE CONCENTRATIONS DURING CIGARETTE-SMOKING [J].
BENOWITZ, NL ;
KUYT, F ;
JACOB, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (06) :758-764
[5]   USE OF ANALOG SCALES IN RATING SUBJECTIVE FEELINGS [J].
BOND, A ;
LADER, M .
BRITISH JOURNAL OF MEDICAL PSYCHOLOGY, 1974, 47 (SEP) :211-218
[6]  
CHURCH RE, 1989, SMOKING HUMAN BEHAV, P239
[7]   NOREPINEPHRINE AND EPINEPHRINE RELEASE AND ADRENERGIC MEDIATION OF SMOKING-ASSOCIATED HEMODYNAMIC AND METABOLIC EVENTS [J].
CRYER, PE ;
HAYMOND, MW ;
SANTIAGO, JV ;
SHAH, SD .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (11) :573-577
[8]  
DEWIT H, 1993, BEHAV PHARMACOL, V4, P29
[9]   Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers [J].
Foulds, J ;
Stapleton, J ;
Swettenham, J ;
Bell, N ;
McSorley, K ;
Russell, MAH .
PSYCHOPHARMACOLOGY, 1996, 127 (01) :31-38
[10]   EFFECT OF SUBCUTANEOUS NICOTINE INJECTIONS ON EEG ALPHA-FREQUENCY IN NONSMOKERS - A PLACEBO-CONTROLLED PILOT-STUDY [J].
FOULDS, J ;
MCSORLEY, K ;
SNEDDON, J ;
FEYERABEND, C ;
JARVIS, MJ ;
RUSSELL, MAH .
PSYCHOPHARMACOLOGY, 1994, 115 (1-2) :163-166